Luyten GPM - Search Results

1

Phenotypic Consequences of the GJD2 Risk Genotype in Myopia Development.

Haarman AEG, Enthoven CA, Tedja MS, Polling JR, Tideman JWL, Keunen JEE, Boon CJF, Felix JF, Raat H, Geerards AJM, Luyten GPM, van Rijn GA, Verhoeven VJM, Klaver CCW. Haarman AEG, et al. Among authors: luyten gpm. Invest Ophthalmol Vis Sci. 2021 Aug 2;62(10):16. doi: 10.1167/iovs.62.10.16. Invest Ophthalmol Vis Sci. 2021. PMID: 34406332 Free PMC article.

2

Concurrent loss of chromosome arm 1p and chromosome 3 predicts a decreased disease-free survival in uveal melanoma patients.

Kilic E, Naus NC, van Gils W, Klaver CC, van Til ME, Verbiest MM, Stijnen T, Mooy CM, Paridaens D, Beverloo HB, Luyten GP, de Klein A. Kilic E, et al. Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2253-7. doi: 10.1167/iovs.04-1460. Invest Ophthalmol Vis Sci. 2005. PMID: 15980208

3

Relationship between retinal detachment and biometry in 4262 cataractous eyes.

Bhagwandien AC, Cheng YY, Wolfs RC, van Meurs JC, Luyten GP. Bhagwandien AC, et al. Ophthalmology. 2006 Apr;113(4):643-9. doi: 10.1016/j.ophtha.2005.10.056. Epub 2006 Mar 9. Ophthalmology. 2006. PMID: 16527355

4

The influence of incision-induced astigmatism and axial lens position on the correction of myopic astigmatism with the Artisan toric phakic intraocular lens.

Bartels MC, Saxena R, van den Berg TJ, van Rij G, Mulder PG, Luyten GP. Bartels MC, et al. Ophthalmology. 2006 Jul;113(7):1110-7. doi: 10.1016/j.ophtha.2006.02.017. Epub 2006 May 19. Ophthalmology. 2006. PMID: 16713627 Clinical Trial.

5

Expression of APITD1 is not related to copy number changes of chromosomal region 1p36 or the prognosis of uveal melanoma.

van Gils W, Mensink HW, Kilic E, Vaarwater J, Verbiest MM, Paridaens D, Luyten GP, de Klein A, Brüggenwirth HT. van Gils W, et al. Invest Ophthalmol Vis Sci. 2007 Nov;48(11):4919-23. doi: 10.1167/iovs.07-0061. Invest Ophthalmol Vis Sci. 2007. PMID: 17962439

6

Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.

van Gils W, Lodder EM, Mensink HW, Kiliç E, Naus NC, Brüggenwirth HT, van Ijcken W, Paridaens D, Luyten GP, de Klein A. van Gils W, et al. Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4254-62. doi: 10.1167/iovs.08-2033. Epub 2008 Jun 14. Invest Ophthalmol Vis Sci. 2008. PMID: 18552379

7

Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.

Maat W, van der Slik AR, Verhoeven DH, Alizadeh BZ, Ly LV, Verduijn W, Luyten GP, Mulder A, van Hall T, Koning F, Jager MJ, van Bergen J. Maat W, et al. Invest Ophthalmol Vis Sci. 2009 Jun;50(6):2888-95. doi: 10.1167/iovs.08-2733. Epub 2009 Feb 21. Invest Ophthalmol Vis Sci. 2009. PMID: 19234348

8

Intravascular presence of tumor cells as prognostic parameter in uveal melanoma: a 35-year survey.

Ly LV, Odish OF, Wolff-Rouendaal Dd, Missotten GS, Luyten GP, Jager MJ. Ly LV, et al. Invest Ophthalmol Vis Sci. 2010 Feb;51(2):658-65. doi: 10.1167/iovs.09-3824. Epub 2009 Sep 24. Invest Ophthalmol Vis Sci. 2010. PMID: 19797220

9

Regulation of VEGF-A in uveal melanoma.

el Filali M, Missotten GS, Maat W, Ly LV, Luyten GP, van der Velden PA, Jager MJ. el Filali M, et al. Invest Ophthalmol Vis Sci. 2010 May;51(5):2329-37. doi: 10.1167/iovs.09-4739. Epub 2009 Dec 30. Invest Ophthalmol Vis Sci. 2010. PMID: 20042655

10

A comparison of HLA genotype with inflammation in uveal melanoma.

van Essen TH, Bronkhorst IH, Maat W, Verduyn W, Roelen DL, Luyten GP, Jager MJ. van Essen TH, et al. Invest Ophthalmol Vis Sci. 2012 May 4;53(6):2640-6. doi: 10.1167/iovs.11-8901. Invest Ophthalmol Vis Sci. 2012. PMID: 22447860

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

186 results

Search Page